___

• [1] Liu Y, Sun W, Guo Y, et al. Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study. Platelets. 2020; 31(4): 490-496.
• [2] Zulfiqar AA, Lorenzo-Villalba N, Hassler P, et al. Immune thrombocytopenic purpura in a patient with COVID-19. N Engl J Med. 2020; 382(18): e43.
• [3] Cooper N, Ghanima W. Immune Thrombocytopenia. N Engl J Med. 2019; 381: 945-955.
• [4] Swinkels M, Rijkers M, Voorberg J, et al. Emerging Concepts in Immune Thrombocytopenia. Front Immunol. 2018; 9: 880.
• [5] Cao W, Liu X, Bai T, et al. High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019. Open Forum Infect Dis. 2020; 7(3): ofaa102.
• [6] Bhattacharjee S, Banerjee M. Immune Thrombocytopenia Secondary to COVID-19: a Systematic Review. SN Compr Clin Med. 2020; 19: 1-11.
• [7] Jansen AJG, Swart RM, te Boekhorst PAW. Thrombopoietinreceptor agonists for immunethrombocytopenia. N Engl J Med. 2011; 365: 2240-2241.